Cost-Effectiveness of Cervical Cancer Screening With Human Papillomavirus DNA Testing and HPV-16,18 Vaccination

BACKGROUND: The availability of human papillomavirus (HPV) DNA testing and vaccination against HPV types 16 and 18 (HPV-16,18) motivates questions about the cost-effectiveness of cervical cancer prevention in the United States for unvaccinated older women and for girls eligible for vaccination. METH...

Full description

Saved in:
Bibliographic Details
Main Authors: Goldhaber-Fiebert, Jeremy D., Stout, Natasha K., Salomon, Joshua A., Kuntz, Karen M., Goldie, Sue J.
Format: Artigo
Language:Inglês
Published: 2008
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3099548/
https://ncbi.nlm.nih.gov/pubmed/18314477
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jnci/djn019
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items